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Proteomics concerns itself with the characterization and function of all cellular proteins, the 
ultimate determinants of cellular function. Mass spectrometry has emerged as the preferred 
method for in-depth characterization of the protein components of biological systems. Using 
mass spectrometry, key insights into the composition, regulation and function of molecular 
complexes and pathways have been gained. Now days, mass spectrometry-based proteomics has 
become an indispensable tool in the cellular and molecular life sciences. This review discusses 
current mass spectrometry-based proteomics technologies. 
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INTRODUCTION 
1. Introduction to proteomics 
     A large number of DNA sequences from 
a wide range of organisms, including 
humans and mammals, have been produced 
by genomic projects. However, the genome 
determines only the proteins, which are 
produced by the cell and thus set the 
framework within which most of the highly 
complex intracellular processes takes place.  
In a long sequence of events, resulting in 
the syntheses of the proteins, the 
construction of the mRNA is merely the 
first step (Figure 1). 
  
Figure 1. The mechanisms by which a single gene can give rise to multiple gene products [1] 
 
     Firstly, preRNA is exposed to 
posttranscriptional control in the form of 
polyadenylation, and mRNA editing, 
sometimes including alternative splicing 
[2]. At this step several different protein 
isoforms can be generated from a single 
gene. Secondly, the mRNAs are exposed to 
a regulation at the level of protein 
translation [3]. Those proteins, having been 
synthesized, are sometimes exposed to a 
posttranslational modification. It is believed 
that up to 200 different types of 
posttranslational protein modifications can 
be found [4]. The other mechanisms by 
which proteins are regulated, are 
proteolysis and compartmentalization  [5, 
6]. 
The average number of proteins produced 
per gene is estimated to be one to two in 
bacteria, three in yeast and more than 10 in 
humans (Table 1). Furthermore, a mRNA 
level has been quantified in many studies. 
A number of groups have produced data 
showing little or no correlation between the 
steady state protein levels and the mRNA 
abundance levels [7,8].  Thus, the 
complexity is found primarily at the protein 
level, not at that of the genome. The 
proteins, rather than the mRNA, influence 
the majority of the processes in the cell. 
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The proteins show a very broad range in 
concentrations, with a dynamic range in 
copy numbers of protein 10
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Investigating the proteome of the cell 
gives a more representative picture of 
the cell at the molecular level. The 
proteome is defined as the time- and 
cell- specific protein complement of the 
genome and therefore encompasses all 
the proteins that are expressed in a cell 
at one time, including the isoforms and 
the posttranslational modifications [12]. 
The genome is static by nature, 
essentially identical in every cell of an 
organism, whereas the proteome is 
dynamic, constantly changing and 
responding to internal and external 
stimuli. The study of the proteome, 
called proteomics, includes the 
identification, characterisation and 
quantification of a complete set of 
proteins expressed by the entire genome 
in the lifetime of a given cell, tissue or 
organism. This encompasses isoforms 
and modifications, protein-protein 
interaction and the structure description 
of proteins and their complex [13]. 
 
Table 1. Complexity reflected in the proteomes. E. Coli, Escherichia Coli; S. Cerevisiae, Saccharomyces Cerevisiae; 
A. Thaliana, Arabidopsis Thaliana; D. Melanogaster , Drosophila Melanogaster [11]. 
 
Model organism Size of genome 
(Mbp) 
Number of gene Number of protein per gene 
E. Coli 4.6 4300 1-2 
S. Cerevisiae 12 6000 2-3 
A. Thaliana 125 25500 1-2 
D. Melanogaster 100 14000 5-10 
Homo Sapiens 3000 30000-36000 >10 
 
Today proteomics studies are divided into 
five central pillars:  mass spectrometry-
based proteomics, array based proteomics, 
structural proteomics, clinical proteomics 
and informatics. Protein array proteomics 
consists of a large number of protein 
interacting elements such as antibodies or 
peptides that are coated or immobilized on 
a solid support in a distribution-regulated 
manner. The arrayed molecules are then 
used to screen and assess patterns of 
interaction with samples containing distinct 
proteins or classes of proteins. In structural 
proteomics, different techniques, such as 
nuclear magnetic resonance and X-ray 
crystallography, are used to achieve a 
comprehensive coverage of individual 
protein structures or to analyse the 
structures of large protein complexes. 
Clinical proteomics covers a delineation of 
altered protein expressions, the 
development of a novel biomarker for 
diagnosis and/or early detection of diseases, 
and the identification of new targets for 
therapeutics. Informatics proteomics 
appears on several fronts. This field 
includes study designs, development of 
protein databases, and development of 
protein identification tools [14]. I will focus 
on mass spectrometry-based proteomics. 
Mass spectrometry-based proteomics 
approaches are divided into two major 
parts: (i) one – or two-dimensional gel 
electrophoresis for protein separation (gel-
based proteomics), followed by mass 
spectrometry and (ii) one- or two-
dimensional liquid chromatography for 
protein or peptide separation (gel-free 
proteomics) combined with tandem mass 
spectrometry for protein identification.  
Figure 2 gives the general workflow in 
mass spectrometry-based proteomics. In the 
following text, the fundamental principles 
of proteomics using mass spectrometry 
(MS) technology are discussed. Currently, 
MS has been overwhelmingly applied as 




     In the classic proteomics, the first step is 
the separation and visualization of protein 
mixtures by a two-dimensional 
electrophoresis (2-DE), also called two-
dimensional polyacrylamide gel 
electrophoresis (2-D PAGE). The 2-DE is 
54 

















Figure 2. Workflow chart in mass spectrometry-
based proteomics 
 
not a new technique; it was first used in 
1975 in the analysis of proteins. 
The proteins are separated in 2-DE, based 
on their isoelectric points (first dimension) 
and their molecular weights (second 
dimension) (Figure 3). In the first 
dimension, which is called isoelectric 
focusing (IEF), protein separation is  
 
achieved in the context of a continuous pH 
gradient in which proteins migrate to the 
protein in the gel where they have no 
charge (isoelectric point). After the first 
dimension, a number of equilibration steps 
are performed to establish optimal 
physicochemical protein properties for the 
second dimension. During these 
equilibration steps, the proteins are treated 
with sodium dodecyl sulfate (SDS, for 
protein adsorption), a reducing agent such 
as dithiothreitol (DTT, to reduce disulfide 
bonds), and an alkylating agent such as 
iodacetamide (to stabilize newly formed –
SH bonds). Subsequently, in the second 
dimension, electrophoresis is performed, 
usually in a polacrylamide gel (hence the 
term 2D-PAGE), which acts as a sieving 
device. All proteins move toward the 
positive electrode because they are covered 
by negatively charged SDS molecules. The 
amount of the SDS molecules is roughly 
proportional to the size of the protein, 
thereby allowing a separation, based on the 
size of the proteins [15[. The combination 
of IEF and SDS-PAGE in a two 
dimensional separation results in a 
resolution of 10,000 individual spots per 
gel [16]. In practice, depending on the 
sample and on the sensitivity of the 
detection technique, a maximum of 3000 














Figure 3. Two-dimensional electrophoresis (2-DE). Reference protein map of the normal human lympha (silver 
staining) accessible over the Internet [18]. 
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After the 2-DE gel electrophoresis, the next 
step is the detection of proteins. There are 
several methods for the detection of 
proteins in 2-DE gels. Traditionally, it was 
accomplished by the use of a visible stain, 
whereas newer approaches use fluorescent 
dyes.  
After the separation and visualization of the 
protein mixtures, images of gels are 
analyzed by software, for example Melanie 
or Z3. The gel images are analyzed in order 
to detect spot positions, calculate spot 
intensity and remove streaks on gels. Based 
on the algorithms, software packages used 
to analyse gel images can be divided into 
two groups: algorithms based on a direct 
comparison of images by distribution of 
intensity, Z3 [19], and algorithms based on 
spot characteristics, Melanie [20]. 
The 2-DE provides approximate value of 
mass and isoelectric points of a protein, but 
this information is not sufficient to identify 
proteins. To identify proteins of interest, gel 
pieces are excised; peptides are extracted 
after in-gel digestion, then analyzed by 
mass spectrometry. The two most 
commonly used techniques for protein 
characterization in the proteomics are 
peptide mass fingerprinting (PMF) and 
tandem MS of a proteolytic digest of a 2-
DE spot (see 3.1).  
The 2-DE is able to provide an unparalleled 
protein separation, but it has been shown 
that this technology has several limitations. 
These include an inability to detect 
membrane proteins, extreme basic and 
acidic proteins, proteins of a molecular 
weight less than 10 kDa and higher than 
150 kDa and low abundance proteins 
[4,7,21,22]. Because of this 
underrepresentation of several classes of 
protein other methods have been developed. 
 1.2. Liquid chromatography techniques 
     An alternative technique to 2DE is the 
high performance liquid chromatography 
(HPLC/LC), a non-gel based 
protein/peptide separation method. LC is a 
long well-known method applied for the 
separation, identification and determination 
of protein/peptide components in complex 
mixtures. In the LC method 
proteins/peptides are separated based on 
their size (mass), pI (charge) or 
hydrophobicity - the three chemical 
characteristics that define any given 
protein/peptide [23]. Depending of the type 
of liquid and the type of stationary phase, 
many different modes of LC can be run 
[24). In this text we will describe only the 
most popular LC methods used in 
proteomics: the single-dimensional 
reversed-phase LC (RP-LC) and the two-
dimensional strong cation exchanger- 
reversed phase LC (SCX-RP-LC) and the 
recently introduced combined fractional 
diagonal chromatography (COFRADIC) 
[21,25,26]. 
The separation method RP-LC is used in 
most cases for one-dimensional LC. The 
separation mechanism of RP-LC is a 
hydrophobic interaction between the 
column material coated with alkyl chains 
(e.g. C4, C8 or C18) and the protein/peptide. 
The elution usually takes place under acidic 
conditions by a gradient water plus organic 
solvent, e.g. acetonitrile. The RP-LC has 
two advantages; firstly, the relative high 
peak capacity (maximum number of 
components that can be resolved) and 
secondly, the full MS compatibility, which 
allows the MS analysis of the column eluate 
without further treatment [27,28]. 
In spite of RP-LC having been proved to be 
an economic and effective way for protein 
and peptide identification, its use in 
proteomics is relatively restricted by the 
complexity of the samples. Samples in 
proteomic analyses often contain thousands 
of proteins. After proteolytic digestion, the 
hundreds of thousands peptides must be 
separated. This is beyond the analytical 
range of the RP-LC method because of its 
insufficient peak capacity. Thus, 
multidimensional separations are often 
necessary [29,30]. In multidimensional 
chromatography different separation 
mechanisms, the so-called orthogonal 
separation must be combined [31]. The 
most commonly used method in proteomics 
is the strong cation exchanger (SCX) 
chromatography (separation by positive 
charge) combined with the RP-LC [32]. 
This two-dimensional LC is better known 
as multidimensional protein identification 
technology (MudPIT) [33]. A benefit of the 
SCX-RP combination is that the salt ions in 
the SCX fractions, which would otherwise 
interfere with the MS analysis, are extracted 
from the peptide ions in the RP step [34]. 
The MudPIT can be performed off-line or 
on-line. The off-line is defined as LC, not 
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coupled to MS, in contrast to the on-line 
LC, which is connected to the MS. The 
advantage of the on-line method is that 
everything can be done automatically and 
sample loss will be avoided [35]. The 
advantage of the off-line over the on-line is 
an increased loading capacity, an improved 
chromatography, a greater flexibility and 
repeated sample analyses [36]. A major 
disadvantage of MudPIT still is the 
increased complexity. In a typical setup, the 
protein mixtures are digested prior to 
separation. A small calculation of the 
numbers of peptides shows that if a cell has 
between 23.000-40.000 proteins and a 
digest protein gives typical up to 40 





 peptides [5].  
Another peptide-based protein 
identification technique different from 
MudPIT is the combined fractional 
diagonal chromatography (COFRADIC), 
which uses RP-LC [37]. In COFRADIC, 
the proteins are first digested to peptides. A 
subset of peptides, which is highly 
representative of the parent protein 
originally present in the lysate, is then 
selected. COFRADIC thus reduces the 
complexity of the peptide mixture. 
Theoretically, any peptide carrying a group 
that can be specifically modified may in 
principle be selected. It is sensitive and is 
characterized by a broad protein coverage, 
including abundant and rare, large and 
small, acidic and basic and hydrophobic 
proteins. This concept has been applied to 
select methionine containing peptides and 
N-terminal peptides [38,39]. 
2. Introduction to MS 
     One of the most powerful modern 
analytical methods available to the 
laboratory analyst is the MS. Over the last 
decade, MS-based proteomics has rapidly 
become the preferred analytical method for 
the identification and characterization of 
proteins. MS makes it possible for the 
compounds to be identified by the 
production of ions and their subsequent 
separation and detection based on their 
mass-to-charge ratio, offering a very high 
level of specificity with sensitivity. A 
typical mass spectrometer consist of an ion 
source, which generates the ions, a mass 
analyser, where these ions are separated and 
a detector, which delivers the mass 
spectrum (Figure 4) [40]. 
Figure 4. The principle components of a mass spectrometer 
 
In the following text the fundamental 
principles of two of the most common types 
of mass spectrometers, MALDI-TOF and 
ESI-quadrupole MS, are described. 
 
2.1. Ionization source 
2.1.1. Matrix assisted laser desorption / 
ionization (MALDI) 
     MALDI is a soft ionization 
technique used in mass spectrometry 
[41]. Ionization of the molecules to be 
analyzed (analyte) by MALDI is 
obtained in two steps. In the first step, 
the analyte molecules are mixed with a 
matrix (a small, organic, and UV-
absorbing molecule) and is pipetted on 
a sample probe (the target) and allowed 
to dry before analysis. In the second 
step, the resulting solid on the targets is 
irradiated by laser pulses, usually from 
nitrogen lasers with a wavelength of 
337nm, in order to generate analyte ions 
(protonated molecules). The ionisation 
process in MALDI is still unknown 
[42], but it has been suggested that the 
irradiation induces an accumulation of a 
large amount of energy in the 
condensed phase, through an excitation 













This causes a desorption of the ions 
formed by a proton transfer from the 
photoexcited matrix to the analyte 
molecules (Figure 5) [43]. 
Process followed by a desolvation and 
then an introduction into the mass 




Figure 5. Ionization of analytes by MALDI. The co-
crystal of matrix and sample is targeted by a laser, 
causing a desorption  
 
The matrix has two other functions: it 
protects the analyte from the laser pulse by 
absorbing the induced laser energy and it 
changes the energy transfer from the laser 
to the analyte molecules [43]. In large scale 
proteomics, the -cyano-4-
hydroxycinnamic acid (HCCA) matrix is 
recommended. The choice of matrix, 
however, depends on the properties of the 
analyte molecule and the sample 
preparation [44]. MALDI rapidly became 
popular because the time-of-flight (see 
later) mass analyzer most commonly used 
with MALDI is robust, simple, sensitive 
and has a large mass range. Another reason 
for MALDI‟s popularity is that its mass 
spectra are simpler to interpret because the 
ions predominantly contain only a single 
charge (i.e. the mass of neutral analyte plus 
proton- [M+H]
+
). Additionally, MALDI has 
been observed to be less resistant to 
interference from the non-peptidic 
components of a sample, such as salts and 
detergents that always accompany peptides 
into the mass spectrometer [43] 
2.1.2. Electrospray ionization (ESI) 
     Even though MALDI is the most 
efficient method for ionizing peptides, ESI 
is the optimal method of ionization for the 
broadest range of polar biomolecules. The 
ESI process for forming gas-phase ions 
come from the work of Dole et al, but it 
was Fenn´s group at Yale University that 
coupled ESI with mass spectrometry 
[45,46]. Electrospray is a rather simple 
technique for the ionization of polar 
molecules. Figure 6 illustrates the 
electrospray process in the positive-ion 
mode and a photograph of the spray 
produced. Applying a high electrical field 
to a relatively small flow of liquid from a 
capillary tube makes an electrospray. The 
electrospray makes the liquid surface highly 
charged and a spray of charged liquid 
droplets emerge at the end of the capillary 
tube. The polarity of the charged droplets 
can be changed by the applied polarity on 
the capillary. Through the capillary tube to 
which a high voltage is applied, the sample 
solution flows at a low flow rate. 
Presuming positive potential, positive ions 
from the solution will accumulate at the 
surface of the tip. The positive ions are 
drawn out to establish a „Taylor cone‟ 
(Figure 6, A and B). As the liquid is made 
to hold more electric charge, the Taylor 
cone makes a filament form that, when the 
surface tension exceed beyond the applied 
electrostatic force, makes positively 
charged droplets through a budding 
process. The charged droplets will 
evaporate in the area between the needle 
and the collector (the counter electrode). 
The electrical charge density at the surface 
of the droplets increases as the size of the 
droplet decreases. This increases the field 
around the droplet to the point where the 
electrostatic repulsion is greater than the 
surface tension (known as the Rayleight 
limit); it erupts and emits smaller particles. 
Continuous decrease of the droplet size will 
result in the creation of a droplet containing 
a single (or multi-charged) ion. This 
mechanism is better known as the charge 
residue model. A second mechanism (the 
ion-evaporation model) of the gas-phase ion 
production has been suggested in which the 
ion evaporation is believed to occur from 
small, highly charged droplets, with the ion 
formation taking place as a result of the 
repulsion between the charged ion and the 
other charges of the droplet. The relative 
usefulness of the two models remains the 
subject of discussion and research (Figure 
7) [46,49] . 
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Figure 6. Principle of electro spray ionisation, A) schematic  representation of electro spray in the positive mode and 






Figure 7. The mechanisms suggested behind electro spray ionization method.  Adapted from [50] 
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The ESI technique is capable of making 
intact gas-phase ionic species by attaching 
more than one charge to each individual 
molecule. Peptides and proteins are thought 
to be protonated predominantly at the basic 
charge sites: the amino terminus, arginyl, 
histidyl and lysyl residues [45]. The 
resulting mass spectrum of a sample with 
multiple charges shows as a series of ions, 
representing the distribution of charge 
states (Figure 8).  
 
 
Figure 8. Multi-charge spectrum of CheY protein. Inset shows the molecular mass of the CheY interpret by a 
computer software (15052 Da) [51].  
 
A protein ESI mass spectrum seems rather 
complex at first sight; peaks from a given 
protein, however, only differ by the degree 
of protonation where nearest neighbours 
differ by a single charge. Each peak shows 
a measure of the protein‟s mass, and so in 
each spectrum, multiple mass 
measurements are made, thereby enhancing 
the precision of the measurement.  
For two successive peaks at position x1 and 
x2 on the m/z scale and corresponding to 
numbers of the same ion series, then:  
 
x1 = (M+n)/n 
 
where M is the molecular mass and n is the 
number of charges which is equivalent to 
the number of added protons, and 
 
x2 = (M+n+1)/(n+1) 
 
Solving these equation gives: 
 
n = (x2-1)/(x1-x2) 
 
The molecular weight is obtained by taking 
n as the nearest integer value [52]. 
In reality the mass-spectometer data system 
performs such calculations and plots a 
molecular mass spectrum on a zero-charge-
state x-axis (Figure 8). 
 
2.2. Mass analyzer 
2.2.1. The Quadrupole mass filter 
     The quadrupole consist of two pairs of 
metallic rods. The rods are perfectly 
parallel. It is controlled by a combination of 
direct current (DC) and radio frequency 
(RF) voltage. One set of rods is at a positive 
electrical potential and the other one at a 
negative potential. Ions flies in a continuous 
beam along the central axis between the 
poles and are filtered on the basis of their 
m/z ratios. The positive pair of rods is 
functioning as a high mass filter, the other 
pair is functioning as a low mass filter. 
Combining both sets of rods into a 
quadrupole arrangement, which overlaps 
the two mass filter regions, forms a stability 
area. This will allow ions with a certain m/z 
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ratio to pass through. Those ions, which 
have an unstable trajectory through the 
quadrupole mass analyzer will collide with 
the quadruple rods, never reaching the 
detector (Figure 9). The m/z ratio of ions 
that pass through the quadrupole is 
proportional to the voltage applied to the 
rods. In practice, the highest detectable m/z 
ratio is about 4000 Th. Scanning a 
quadrupole mass analyzer involves ramping 
the amplitude of the DC and RF voltage at a 
constant ratio. This will change the position 
of the stable area and allow different 
masses to pass through [43,46,49]. 
 
Figure 9. A schematic presentation of the quadrupole mass filter. Figure adapted from [53] 
 
2.2.2. The time-of-flight (TOF) mass 
analyzer 
      The principle of the TOF mass analyzer 
is to measure the flight time of ions 
accelerated out of an ion source into a field 
free drift tube to a detector. The ions are 
accelerated by potential Vs and fly a 
distance d before reaching the detector. As 
an ion leaves the source with mass m and a 






But velocity (v) = distance (d)/ time (t) and 






 / 2Vse) 
 
The equation shows that ions with different 
mass will take different amounts of time to 
travel the same distance. It also shows that 
the lower the mass of an ion, the faster it 
will reach the detector. 
The most important drawback of the TOF 
analyzer is its poor mass resolution. Mass 
resolution is affected by slight variations in 
flight time, and factors that create a 
distribution in flight times among ions with 
the same m/z ratio will result in a poor mass 
resolution.   
Two techniques have been introduced in 
TOF mass analyzers in order to improve the 
mass resolution. These are better known as 
delayed extraction and the use of an ion 
mirror or reflecton. In the former, a time 
delay between ion formation and extraction 
of ions from the source is introduced. 
Because of the delay, wide spatial and 
temporal distributions can be avoided [54]. 
In the latter technique, the reflecton creates 
a retarding field that deflects the ions, 
sending them back through the flight tube. 
The more energetic the ion, the deeper it 
penetrates the retarding field of the 
reflectron before being reflected. Thus a 
more energetic ion will travel a longer 
flight path and arrive at the detector at the 
same time as less energetic ions of the same 
mass [41].  
2.3. Coupling Ion source to mass 
analyzers 
     MALDI is traditionally coupled to a 
TOF analyzer, which measures the mass of 
the intact peptides and proteins, while the 
ESI is mostly coupled to triple quadrupoles, 
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which allow a generation of fragment ion 
spectra from selected precursor ions. In the 
last few years, the MALDI ion source has 
been coupled to the TOF-TOF analyzer 
[55]  in which two TOF sections are 
separated by a collision cell and 
Quadrupole-TOF (QTOF) [56] analysers in 
which a collision cell is placed between a 
quadrupole mass filter and a TOF analyzer. 
In addition, the QTOF is interchangeable 
with an ESI ion source [57]. 
3. Protein identification 
     The MS-based approaches are now the  
method of choice for most protein 
identification because of improvements in 
genomics and protein databases (Tabel 2) 
and the more powerful computational 
searching techniques. Protein identification 
using MS involves the use of one of two 
established methodologies: peptide mass 
mapping (or fingerprinting) and peptide 
sequencing. Both techniques make use of a 
proteolytic enzyme (typically trypsin) to 
specifically cleave the proteins into peptide 
fragments of a suitable length (mass) for the 
mass spectrometric analysis. The following 
text is a more detailed discussion of these 
methods. 
 
Table 2. Databases used for proteomics searches. 
Name Content Web address 
Swiss-Prot Annotated protein database www.expasey.org/sprot/ 




A comprehensive, nonidentical protein 
sequence database maintained by the 
proteomics department at the Hammersmith 




dbEST The division of GenBank that contains 
"single-pass" cDNA sequences, or Expressed 




RefSeq Comprehensive, integrated, nonredundant set 
of sequences including protein products, for 




NCBInr A comprehensive, non-identical protein 
database maintained by NCBI for use with 
their search tools BLAST and Entrez. The 
entries have been compiled from GenBank 





IPI International Protein Index a non-redundant 
human proteome set constructed from 
UniProtKB/Swiss-Prot, 
UniProtKB/TrEMBL, Ensembl and RefSeq. 
http://www.ebi.ac.uk/Datab
ases/protein.html 
TrEMBL A computer generated protein database 
enriched with automated classification and 




3.1. Peptide mass fingerprinting (PMF) 
     This first type of data applies a peptide 
mass fingerprint (PMF) or a map of the 
peptides derived from digestion of the 
protein (Figure 10). When a protein is 
treated with a site-specific protease like 
trypsin, this results in a peptide mixture. 
The molecular weights of this set of 
peptides are then measured and compared 
to the predicted masses of peptides from the 
theoretical digestion of proteins in the 
database, when cleaved with the same 
protease [58-62].When enough peptides of 
the measured mass and the theoretical one 
overlap, this generally indicates that the 
protein has been identified. This is the case 
even if a few peptide molecular weights 
may not match because of modifications.  










Figure 10. Chart of the peptide mass fingerprinting process. The figure is adapted from [63]  
 
e.g. Mascot and ProFound [64]. Table 3 
gives the names and URLs of a number of 
PMF tools. 
The following information is necessary for 
a protein search: the protein mass range, the 
cleavage reagent, the peptide mass 
accuracy, the peptide masses, the 
modification during the gel process and the 
number of missed cleavages [65].   
PMF is a suitable method for protein 
identification under two conditions. First, 
the method should only be applied when the 
sample to be analyzed contains a purified 
protein (typically, a 2-DE gel spot). The 
method is not reliable for mixtures 
containing more than two or three proteins. 
Second, the method is effective only when 
a species is well represented in the 
sequence databases. If these conditions are 
met, then the method can be an efficient 
manner to proceed [66-68]. However, the 
method can fail to identify the protein of 
interest if: 1) there are not enough peptide 
masses, 2) the peptide is posttranslational 
modified, 3) there are too many artifactual 
peptides in the spectrum, such as keratin 
peaks [69]. 
 
Table 3. Available PMF tools. 
 









3.2. Peptide sequencing 
     Protein identification by tandem mass 
spectrometry (MS/MS) is a key to most 
proteomics projects (Figure 11). The 
MS/MS spectra represent peptides that are 
produced by proteolysis of a protein prior to 
MS/MS analysis. The masses of the 
fragments are measured and reported as a 
raw spectrum, after isolation and 
fragmentation of one peptide type.  
Peptide sequencing involves the production 
of fragment ion spectra by tandem MS. 
Peptide ions undergo fragmentation along 
the peptide backbone when they are 
introduced into the collision chamber of 
MS where they interact with the collision 
gas (usually nitrogen or argon). A 
nomenclature has been created to indicate 
what types of ions have been generated, 
since peptides can undergo multiple types 
of fragmentation. There are three different 
types of bonds that can be fragmented along 
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the amino acid backbone: the NH-CH, CH-
CO and CO-NH. Each bond breakage gives 
rise to two species, one neutral and the 
other one charged, and only the charged 






Figure 11. A typical MS/MS-based proteomics experiment [40] 
 
The charge remains on either of the two 
fragments, depending on the chemistry and 
relative proton affinity of the two species. 
Hence there are six possible fragment ions 
for each amino acid residue and these are 
labeled as in Figure 12, with the a, b and c 
ions having the charge retained on the N-
terminal fragment and the x, y and z ions 
having the charge retained on the C-
terminal fragment. The most common 
cleavage sites are at the CO-NH bonds, 
which gives rise to the b and y ions. The 
mass difference between two adjacent b or 
y ions is indicative of a particular amino 
acid [70]. In addition to the fragmentation 
along the peptide backbone, cleavage 
occurs along amino acid side chains [71]. 
The types of ions detected in an MS/MS 
experiment vary with the peptide, the 
activation step, the instrument‟s observation 
time frame, and/or instrument 
discrimination factors [72,73]. 
MS/MS identification consists in 
correlating the sequence of peptides, 
present in a sample with their 
corresponding theoretical amino acid 
sequences, obtained from a protein or 
genomic database. When the amino acid 
sequence of a peptide is identified, it is used 
to search databases to find the protein from 
which it was derived. The MS/MS database 
matching, however, works optimal with 
peptides that match exactly the correct 
sequence in a database. 
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a2 b2 c2 a3 b3 c3
z1 x2 y2 z2 x3 y3 z3  
Figure 12. Fragmentation nomenclature of peptides [70].  
 
There are several reasons why a spectrum 
might not match a sequence entry: if the 
peptide has undergone a non-specific 
proteolytic cleavage, if the peptide contains 
chemical in case of pre-, co- or post-
translation modifications, in case of 
sequence polymorphisms, and finally if 
there are errors in the database sequences. 
In addition, other reasons may be a pitfall 
for identification algorithms: a spectrum 
may originate from a non-peptide 
contaminant or may be too noisy; it may 
originate from multiple peptides with the 
same m/z; the precursor mass may be 
incorrectly interpreted (e.g. because of 
incorrect precursor charge assignment); 
unusual fragmentation patterns may disturb 
the identification algorithms, for example 
due to the non-availability of a mobile 
proton. The major disadvantage of 
performing MS/MS is that the process is 
not easily automated. As a result, analysis 
and interpretation of the mass spectra are 
time-consuming processes. 
4. Quantitative proteomics 
     One of the goals of proteomics research 
is to quantify proteins in the biological 
system. For practical purposes this field of 
proteomics is better known as expression 
proteomics. In this approach, the entire 
proteome or subproteome of samples from 
different biological states, e.g. normal 
versus disease, are compared [74]. There 
are different approaches for quantitative 
proteomics (Figure 13). In the following 
text the most developed quantification 
methods will be described.  
 
4.1. 2-DE 
     The technique that is still the most 
widely used in quantitative analysis is the 
2-DE, as explained in point 1.1. This 
technology has gained popularity for its 
unparalleled separation performance and its 
ability to provide relative protein 
quantification via visible staining reagents 
or fluorescent dyes. The most commonly 
used visible stain has traditionally been the 
silver stain or Coomasie blue. The silver 
staining is the more sensitive stain, 
detecting proteins in the 2-5 ng range, 
compared to the Coomassie staining, where 
the detected protein is over 40 ng [75]. 
However, the silver staining has decreased 
in popularity due to complications with 
background and reproducibility. The 
Coomasie blue staining is rather insensitive 
and a large number of proteins remain 
undetected using this method [76]. Because 
of these limitations, fluorescent dyes have 
been developed. This method relies on a 
fluorescence prelabelling of the protein 
mixtures before the 2-DE gel 
electrophoresis. The protein samples are 
labelled with up to three spectrally distinct, 
charged and mass-matched fluorescent 
dyes, known as CyDye DIGE fluors. 
The labeled proteins then are mixed and 
then co-electrophoresed on the same 2-DE 
gel. The different protein extracts labeled 
with different CyDye DIGE fluors may 
then be visualized separately by exciting 
the different dyes at their specific excitation 
wavelengths. This is achieved by the use of 
an imager containing the appropriate laser 
wavelength for exciting the different dyes 
and a filter for collecting the light emitted. 
Each dye generates digital images of each 
individual sample. The advantages of this 
technique are its ability to overcome the 
reproducibility problem in the 2-DE and an 
improved sensitivity and accuracy. The 
sensitivity of the CyDye DIGE fluor 
minimal dyes are: Cy2 0.075ng, Cy3 
0.025ng and Cy5 0.025ng.
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Figure 13. Strategies for quantitative proteomics profiling  
 
The major drawback of this staining 
technique is that it is a property of GE 
Healthcare and requires expensive and 
specific equipment, such as a three-laser 
fluorescent scanner and dedicated software 
[77-79]. 
However, because of the limitations of the 
2-DE, such as the existence of multiple 
gene products in one spot which make 
quantification difficult, over the past few 
years protein quantification approaches 
have rapidly evolved towards methods 
providing a higher throughput, a wide 
sample applicability and a smaller sample 
requirement [80]. 
  
4.2. Stable Isotope labeling 
     The alternative techniques that have 
been developed are mass spectrometry 
based on stable isotope labeling (Figure 
13). Quantification in MS-based 
proteomics, using stable isotope dilution, 
makes use of the fact that the two analytes 
that differ only in stable isotope 
composition will be almost chemically 
identical, yet can be differentiated in a mass 
spectrometer, due to their mass difference. 
The ratio of the ion currents for the analyte 
pair will be equal to the abundance ratio for 
the two analytes. Therefore, a relative 
abundance of proteins in different cell or 
tissue states can be calculated, and an 
absolute abundance can be measured with 
the use of isotopically labeled standards 
[46,47,81,82].  
The mass spectrometry based on the stable 
isotope labelling strategy may be divided 
into two classes (1) stable isotope labelling 
of proteins that is achieved metabolically in 
vivo; (2) stable isotope labelling that is 
achieved chemically or enzymatically in 
vitro.  
4.2.1. In vivo labelling 
     Metabolic labelling is a method adapted 
for quantitative proteomics. Nutrients 
highly enriched with stable isotopes are 
provided to cells in culture, and isotope 





     The first approach developed for in vivo 
stable isotope labelling, utilizes media 
containing 
15
N. In this procedure, cell 
cultures are grown in two separate media, 
one containing 
15
N, and the other 
containing standard 
14
N. The cells are then 
pooled together; proteins extracted, 
digested to peptides and quantified on ESI-
LC/MS. Cells grown in media enriched 
with 
15
N are used as an internal standard for 
all quantitative measurements. These 
internal standards are mixed with cells from 
different conditions early during the sample 
preparation so that any protein loss during 
cell lysis, digestion and measurement are 
accounted for by their respective 
15
N-
labelled proteins. The MS measurement 
readily differentiates between the resultant 
peptides from the two types of media. The 
ratios between the intensities or the areas of 
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the isotopically labelled peptide pairs 
directly reflect the difference in the amount 
of a given protein in two different cell pools 
[83-85].   
   
4.2.1.2. Select isotopic labelling amino 
acid incorporation (SILAC) 
     Several researchers have described the 
use of selected stable isotope-incorporation 
for quantifying protein/peptide levels 
between two given cell lines. In this 
approach, the stable isotope labelling 
strategy termed SILAC (Stable Isotope 
Labelling by Amino Acids in Cell Culture), 
two groups of cells are grown in culture 
media where one contains the essential 
“light” amino acids and the other the 
essential “heavy” amino acid (e.g., L-
arginine and 
13
C-labelled L-arginine). By 
using essential amino acids, the cells are 
forced to use them and consequently 
incorporate them into all proteins as they 
are synthesized. Here, instead of 
isotopically labelling the entire pool of 
amino acids with 
15
N, only the selected 
amino acids are labelled. The substitution 
of an isotopic amino acid in the growth 
media does not alter the cell growth, cell 
morphology, doubling time, or the ability to 
differentiate, and hence can be used as a 
powerful quantitative tool for proteomic 
analysis [86-88].  
However, metabolic labelling has its 
limitations because it relies on 
proteomics samples derived from cell 
cultures. Other samples of interest, for 
example clinical tissue samples, are not 
amenable to this technique. Therefore 
other techniques are developed. 
 
4.2.2. In vitro labelling 
     When metabolic labelling of proteins is 
not possible or not desirable, chemical-
labelling techniques (in vitro) can be used 
as an alternative quantitative tool. In vitro 
stable isotope labelling can be applied 
universally for any type of sample, which is 
a major advantage of this technique over 
the in vivo metabolic labelling method 
described above. However, higher technical 
variations in the sample-processing step 
must be expected, compared to the in vivo 
metabolic labelling method. This variation 
appears because the two sample groups for 
the in vitro technique cannot be mixed until 
the isotope labelling has been 
accomplished, and the mixing usually takes 
place after the digestion of proteins. In the 
following text the most applied and recently 
developed technology will be described. It 
is worth mentioning that not all in vitro 
labelling techniques are well developed yet. 
This means that the advantages and 
disadvantages of some of the methods are 
not clear.  
 
4.2.2.1. ICAT 
     Isotope coded affinity tags (ICAT) 
methodology is a well developed method 
for protein quantitation [89-91]. An 
example of the ICAT technology is shown 
in Figure 14.  
The proteome extract from two different 
samples are covalently linked with one of 
two forms of the ICAT reagents, an 
isotopically light form in which the linker 
contains eight hydrogens or a heavy form in 
which the linker contains eight deuterium 
atoms. The ICAT reagent consists of three 
functional groups: an affinity tag (biotin) 
that is used to isolate ICAT-label peptides, 
a linker that incorporates stable isotopes 
and finally a reactive group, which reacts 
with cystein residues in the protein via a 
thiol group. After labelling, the samples are 
mixed. The combined sample is digested by 
a protease, usually trypsin. The ICAT-
tagged peptides are selectively 
enriched/recovered by avidin-biotin affinity 
chromatography and then analysed by ESI-
LC-MS/MS. Each cysteinyl peptide appears 
as a pair of signals, differing by the mass 
differential encoded in the mass tag. The 
relative ion intensities of peptides indicate 
precisely the ratio of abundance of the 
protein from which the peptide originates, 
and the MS/MS spectrum of either isotopic 
form of the peptide allows the protein to be 
identified. Similarly to other existing MS-
based strategies for protein quantification, 
the ICAT approach has its advantages and 
disadvantages. The ICAT technology can 
be applied for the proteome extracted from 
bodily fluids, cells and tissues. The 
specificity of the ICAT reagents helps to 
reduce the complexity of the sample 
mixtures analysed during the LC phase. The 
drawbacks of this method include: the size 
of the ICAT chemical group (average 
MW=570.5 Da) may complicate database-
searching algorithms, especially for short 
peptides (<7 amino acids). These 
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limitations would influence searches based 
on the LC/MS data. The method fails for 
Cys-free proteins or proteins that might 
contain posttranslationally modified Cys 
[93]. 
 
Figure 14. Two populations of proteins from different cellular states or growth conditions are isolated, and each 
population is tagged with a different isotope-coded affinity tag (ICAT) [92].  
 
Recently, a second generation of ICAT 
reagents has become commercially 
available, making the technology widely 
available. The new version of the ICAT 
reagent allows a removal of an acid-
cleavable bond of the biotin moiety, prior to 
MS and utilizes (13)C substitution for 
(12)C in the heavy-ICAT reagent, rather 
than (2)H (for (1)H) as in the original 





     A very straightforward technique for 
quantitative proteomics is to perform a 
tryptic digestion of one sample in H2
16
O 
and the other in H2
18





O isotopes can 
be incorporated into the C-termini of 
peptides (Figure 15). When the proteolysis 
of the control and experimental samples is 





the peptides are differentially coded 
according to the sample origin [81]. The 
relative quantity of proteins is determined 





labelled peptides measured by mass 
spectrometry. 
The advantages of the 
18
O labelling include: 
the simplicity of the method and the 
separation of the labelling procedure from 
experimental conditions. Furthermore, 
unlike the metabolic labelling approach, the 
proteolytic 
18
O-labelling technique works 
equally well with all samples. The method, 
however, requires separate proteolytical 
digestions of the paired proteome pools, 
which can lead to a decreased precision. In 





O-labelled peptides are 
only 2 Da or 4 Da, the proteolytic labelling 
technique has a limited usefulness for larger 




O-labeled separated peptides 
overlap [25,100]. Another pitfall of the 
method is the possible incomplete 
incorporation of isotopic labels due to the 
use of enzyme [101].  
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Figure 15.   General scheme of the 18O labelling procedure. Figure adapted from  [102]. 
 
4.2.2.3. MCAT 
     Another technique, Mass-Coded 
Abundance Tagging (MCAT) can be used 
to compare the relative peptide abundances 
of two samples in complex mixtures [103]. 
As in the case of the ICAT, this approach is 
based on the principle of selective labelling 
of only a specific amino acid residue. In the 
MCAT, at a high pH, O-methylisourea is 
used after proteolysis of the sample by 
trypsin in order to selectively guanidinate 
the -amino group of the C-terminal lysine 
residues in the resulting peptides (Figure 
16). This modification converts lysine into 
homoarginine, which is 42 atomic mass 
units heavier than lysine. The relative 
abundance of treated and untreated sister 
peptide species from the two samples can 
thus be estimated by measuring the ion 
signal intensities in a full scan LC/MS 
mode. The advantage of the MCAT is that 
it does not affect the peptide amino 
terminus or the other side group. 
Furthermore, guanidination increases the 
ionisation efficiency. However, the MCAT 
is only possible if glycine is the N-terminal 
residue [81,104].  
 
4.2.2.4. Global internal standard 
technology (GIST) 
     Proteolytical cleavage of proteins 
generates a primary amine at the amino 
terminus of the peptides that, along with the 
primary amine on lysine residues, is easily 
acylated [105]. Coding by acylation is a 
global strategy often referred to as a global 
internal standard technology (GIST). The 
GIST protocol involves the proteolytic 
digestion of control and experimental 
samples, followed by an isotopic labelling 
of the resulting tryptic peptide by 
deuterated and nondeuterated versions of 






acetoxysuccinimide.  After labelling, 
samples are mixed, and the peptide pair are 
relatively quantified by using the ion signal 
intensities from the LC/MS run [106]. 
The strength of the method lies in the fact 
that all peptides in the digest are universally 
labelled, independent of amino acid 
composition or post-translation 
modification (except from the N-terminal 
block amino terminus of proteins). The 
pitfall of GIST is that acylation reduces the 
charge on C-terminal lysine containing 
peptides, which reduces ionisation 
efficiency [105].  
 
4.2.2.5. iTRAQ 
     In the iTRAQ technology, the proteome 
of four different samples are separately 
extracted and digested. The resulting 
peptides are modified by the different 






























Figure 16. The guanidination reaction selectively modifies lysine  
 
In the iTRAQ technology, peptides are 
labelled with isobaric reagents. These 
reagents contain a primary amine reactive 
group, which covalently binds to all 
peptides (N-termianl or -amino group of 
lysine) in a given sample digest, a reporter 
group of different mass (114,115,116 and 
117 Daltons) and a balancer group (31-28 
Daltons), which balances the mass of the 
reporter group. Due to the isobaric mass 
design of the iTRAQ reagents, 
differentially labelled peptides appear as 
single peaks in MS scans, thus reducing the 
probability of peak overlapping. The 
relative quantitation takes place in the 
MS/MS mode. When the iTRAQ tagged 
peptides are subjected to MS/MS analysis, 
the mass balancing group is released as a 
neutral fragment and the reporter group 
ions are generated. The peak areas of these 
ions represent the relative amount of a 
given peptide in the respective proteome 
extracted (Figure 17) [107,108]. The 
strength of the iTRAQ methodology is that 
the reporter group ions appear in the low-
mass region, which is essentially free of 
other common ions. This reduces the error 
in the relative quantification [110]. An 
inherent drawback of the iTRAQ 
technology is that quantitative information 
is only obtained on those peptides that are 
subjected to the MS/MS analysis, e.g. the 
three most abundant peptides per MS 
survey scan obtained in the nano-HPLC-
MS/MS runs [111]. Another disadvantage 
of the iTRAQ is that it suffers from the 
peptide overabundance problem and must 
be coupled with one or more dimensions of 
liquid chromatographic separation before 
the MS analysis, in order to limit the 
number of isobaric tagged peptides in the 
first MS dimension [112]. 
4.3. Intensity based quantification 
     Isotopic labelling of proteins is not 
always practical and has several 
disadvantages. For example, labelling with 
stable isotopes is expensive. Furthermore, 
there may not be enough different isotopes 
to allow for a simultaneous quantification 
of proteins from multiple samples [88]. As 
an alternative, several groups have 
presented methods of peptides and protein 
quantification without isotopic tags by 
comparing peptide signal intensities, 
measured in sequential ESI-MS analyses 
[113,114]. The signal intensity based 
quantification has the advantage that  the 
observed linear correlation between peak 
areas of the measured peptides and their 
abundance [115]. The use of signal 
intensities for quantification is of particular 
interest in cases where the isotopic labelling 
is impractical or not feasible. It has for 
example been used for the quantification of 
protein present in multiple cellular fractions 
[116]. A major disadvantage of the peptide 
quantification by signal intensity is that it 
often includes experimental variation and 
signal to noise ratios which may affect the 
quantitative value and accuracy [88]. 
Additionally, no free user-friendly software 
is available.   
 
4.4. PAI 
     A single LC-MS/MS analysis can easily 
generate a long list of identified proteins 
with the help of database searching, and 
additional information may be extracted, 
such as the probability score, the number of 
identified peptides per protein, LC retention 
times and so on. 
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Figure 17.  Strategy for relative quantification by the iTRAQ technology. Figure adapted from [109] 
 
Some parameters, such as hit rank, score, 
and the number of peptides per protein, 
may be considered as indicators for the 
protein abundance in the analysed sample 
[117].  
It has been observed that there is a linear 
correlation between the number of peptides 
sequenced per protein and the amount of 
protein present in the mixture. Because 
larger proteins can give rise to more 
peptides, a protein abundance index (PAI) 
is defined. In the PAI index, the 
theoretically observable peptides are used 
for normalization. The PAI index represents 
the number of identified peptides (Nobserved) 
divided by the number of theoretically 
observable tryptic peptides (Nobservable) 
[118]:  
 
PAI = (Nobserved) / (Nobservable) 
More recently, a refined version of PAI has 
been developed [119]. The Exponentially 
Modified Protein Abundence Index 
(emPAI) shows an even better linear 
correlation between the number of peptides 





 – 1 
 
The following example illustrates the 
application of the emPAI index: the protein 
pyruvate kinase is digested in silico, with 
one missed tryptic cleavage, and results in 
76 peptides. Assuming that a nano-LC-ESI-
MS/MS identify 35 unique peptides of the 
pyruvate kinase, the PAI and the emPAI 
values are:  
 
PAI = 35/76~ 0.46 and emPAI= 1.88 
 
Furthermore, the emPAI index can be used 
to express the molar fraction in a sample 
directly. The protein contents in molar 
fraction percentages are described as: 
 
Protein content (mol %) = (emPAI /∑ 
emPAI) × 100 
 
∑ emPAI is the summation of the emPAI 
values of all identified proteins of a sample. 
 
emPAI can be used for relative 
quantification, especially in the cases where 
the isotope-based approaches can not be 
applied because the quantitative changes 
are too large for accurate measurements of 
ratios, or in the cases where a metabolic 
labeling is not possible, or in the cases 
where sensitivity constraint does not allow 
chemical labeling techniques [119]. 
In such cases, the emPAI values of the 
proteins in one sample may be compared to 
those in another sample, and the outliers 
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from the emPAI correlation between the 
two samples may be determined as 
increasing or decreasing proteins [120-122]. 
 
5. Studies of higher-order structures with 
MS 
     MS can be used to study the primary 
structures as well as the secondary, tertiary 
and quaternary structures of proteins 
[49,123,124]. In the following text we will 
describe the application of MS for 
disulphide bonds and protein folding. 
5.1. Disulfide bond 
     Many proteins contain disulfide bonds 




Figure 18.  A disulfide bond formed by two cysteine 
residues 
 
The disulfide bonds play a role in the 
stabilization of the tertiary and quaternary 
structure of proteins. For proteins it is 
important to characterize the disulfide-
pairing pattern. Some proteins contain free 
cystein residues, not involved in disulfide 
bonds, and it is important to identify these 
residues. Although analytical methods have 
been developed to determine the thiol 
content in a protein, the determination of 
the locations of the disulfide bonds is more 
of a challenge. The total cysteine content 
can be determined by a complete reduction 
of the disulfide bonds with a suitable 
reagent (DTT or -mercaptoethanol are 
commonly used), followed by alkylation 
with iodacetic acid or iodacetamide. If the 
procedure is repeated, but without prior 
reduction, only the free cysteins, not 
involved in disulfide bonds, are alkylated. It 
should be mentioned that some proteins 
may have free cysteines buried inside the 
tertiary structure, preventing them from 
being alkylated. The protein mass are then 
measured by mass spectrometry. The total 
mass increment of the intact protein after 
this procedure divided by the mass of the 
alkylating group yields the number of 
cysteins in the protein [125,126].  
5.2. Protein folding 
     Proteins have evolved to carry out a 
wide range of specific functions, such as 
biomedical catalysis, transport, signalling 
and energy conversion. The higher order 
structure adopted by the polypeptide chains 
of a protein depends on its solvent 
environment. Proteins fold into a unique, 
highly ordered and compact structure under 
various physiological conditions of pH and 
temperature. This “native” confirmation is 
vital to the function of proteins. The native 
state of a protein corresponds to the 
confirmation with the lowest overall free 
energy [127]. Studying the way in which 
proteins fold is of fundamental importance 
for proteomics and structure genomics [13] 
and for de novo synthesis of proteins [128]. 
MS can provide information that is 
complementary to data obtained from more 
traditional techniques, such as nuclear 
magnetic resonance, optical spectroscopy, 
or calorimetry [129,130].  
     Electrospray ionisation mass 
spectrometry has often been used to study 
protein folding and unfolding [131]. As 
explained in 2.1.2, protein spectra recorded 
in the positive/negative ion mode typically 
shows a number of peaks that correspond to 
protein ions in different protonation states. 
Studies have shown that protein 
electrosprayed from solution conditions, 
that is in native confirmation tend to have a 
low net charge, whereas in the denaturing 
solution conditions (e.g., acidic, elevated 
temperatures, organic solvents) produce 
much higher charge peaks. Figure 19 shows 
an  example of the ESI mass spectra 
recorded of cytochrome c protein under 
“native” and different pH solution 
conditions.  As seen in the figure, protein 
under compact native state has a narrow 





 state, whereas in the unfolded 
condition (low pH) it has a broad charge 














Figure 19. The various charge state distributions obtained by electrospray mass spectrometry from cytochrom c 
protein in water that contains 3% methanol and 0.5 mM ammonium acetate at A) pH 6.4, where the compact native 
state is fully populated, B) pH 4.2, C) pH 2.6, to D) pH 2.3, where the protein is completely unfolded, and hence can 
accommodate more positive charges. At intermediate pH values, the biomodal distribution demonstrates the co-
existence of folded and unfolded state. Adapted from [131].  
 
6. Concluding remarks 
     As it can be seen from the reviewed 
literature, any mass spectrometer having 
tandem mass analysis capabilities, 
regardless the ion source, mass analyser or 
separation technology to which it is 
interfaced, can be used for protein 
characterization. Specialized instruments 
with increased resolution and scan speed 
are providing and will continue to provide 
enhanced analytical capabilities, showing 
better performance in certain types of 
analyses. The fast developments of mass 
spectrometers in parallel to the advances in 
protein chemistry provide us with new 
ways for asking biological questions. It is 
likely that gel-free MS-based proteomics 
will occupy a central role in biological 
research, providing accurate measurements 
of changes in biological functions, which 
will be elegantly coded by researchers as 
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